Relay Therapeutics
Cambridge
About Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $1.4B
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2024)
- Ticker: nasdaq:RLAY
- Website: relaytx.com
- Phone: (617)370-8837
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/relay-therapeutics-96397 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.